Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine-Reference-Cited by-同舟云学术

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine

Published:2004-06 Issue:17-18 Volume:22 Page:2234-2243
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Borja-Cabrera Gulnara Patricia,Cruz Mendes Amanda,Paraguai de Souza Edilma,Hashimoto Okada Lilian Y,de A Trivellato Fernando Antonio,Kawasaki Jarbas Kiyoshi A,Costa Andreia Cerqueira,Reis Alexandre Barbosa,Genaro Odair,Batista Leopoldina Maria Melo,Palatnik Marcos,Palatnik-de-Sousa Clarisa Beatriz

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference50 articles.

1. Control of zoonotic visceral leishmaniasis. Is it time to change strategies;Tesh;Am. J. Trop. Med. Hyg.,1995

2. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil;Palatnik-de-Sousa;Am. J. Trop. Med. Hyg.,2001

3. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy;Alvar;Ann. Trop. Med. Parasitol.,1994

4. Le diagnostic précoce de la leishmaniose canine par la ponction ganglionnaire. Réflexions à propos de soixante examens positifs obtenus en dix mois dans la région Marsellaise;Ranque;Bull. Acad. Nat. Med.,1948

5. Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, parasitological, therapeutical and epidemiological findings (1977–1983);Marzochi;Mem. Inst. Osw. Cruz.,1985

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components;Vaccine;2024-01

2. Shatavarin-IV saponin adjuvant elicits IgG and IgG2b responses against Staphylococcus aureus bacterin in a murine model;Heliyon;2023-04

3. QuilA® adjuvanted Coxevac® sustains Th1-CD8+-type immunity and increases protection in Coxiella burnetii-challenged goats;npj Vaccines;2023-02-14

4. Infection and Immunity;Clinical Immunology;2023

5. Feasibility of Therapeutic Vaccine for the Management and Control of VL;Challenges and Solutions Against Visceral Leishmaniasis;2023